Masaki Terabe

12PUBLICATIONS
49CO-AUTHORS
Innate immunityCharacterisation of biological macromoleculesMolecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 06, 2026
Vaccination targeting the novel endogenous tumor-associated antigen Gpr149 induces protective immunity against checkpoint inhibitor-refractory SB28 glioblastoma.

|Sep 25, 2026
Structure-based analysis reveals a hydrophobic pocket governing P2Y12 receptor agonist potency and selectivity.

|Jun 29, 2026
Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity.

|May 29, 2026
Inhibition of chemokine CXCL12 modulates the tumor microenvironment in glioblastoma and potentiates immune checkpoint inhibitor efficacy in a tissue-specific manner.

|Feb 02, 2026
Increased immunogenicity of hypermutated SB28 syngeneic glioblastoma is partially mediated by alterations in tumor chemokine expression.

Kevin Thomas Breen, Tuesday Haynes, Matthew Bryce Watowich

|Oct 01, 2025
Characterization of MAIT cells in glioblastoma reveals a potential immunosuppressive role through a MAIT-neutrophil axis.

Seketoulie Keretsu, Taijun Hana, Alexander Lee

Pageof 2

Frequent Collaborators

4 joint publications

Hideho Okada

2 joint publications

Laila Latifi

2 joint publications

Michael Bryan

2 joint publications

Vinnycius Pereira-Almeida